Abstract
BackgroundPremature ovarian failure (POF) remains a clinically challenging entity because in vitro fertilisation (IVF) with donor oocytes is currently the only treatment known to be effective.MethodsA 33 year-old nulligravid patient with a normal karyotype was diagnosed with POF; she had a history of failed fertility treatments and had an elevated serum FSH (42 mIU/ml). Oocytes donated by her dizygotic twin sister were used for IVF. The donor had already completed a successful pregnancy herself and subsequently produced a total of 10 oocytes after a combined FSH/LH superovulation regime. These eggs were fertilised with sperm from the recipient's husband via intracytoplasmic injection and two fresh embryos were transferred to the recipient on day three.ResultsA healthy twin pregnancy resulted from IVF; two boys were delivered by caesarean section at 39 weeks' gestation. Additionally, four embryos were cryopreserved for the recipient's future use. The sister-donor achieved another natural pregnancy six months after oocyte retrieval, resulting in a healthy singleton delivery.ConclusionPOF is believed to affect approximately 1% of reproductive age females, and POF patients with a sister who can be an oocyte donor for IVF are rare. Most such IVF patients will conceive from treatment using oocytes from an anonymous oocyte donor. This is the first report of births following sister-donor oocyte IVF in Ireland. Indeed, while sister-donor IVF has been successfully undertaken by IVF units elsewhere, this is the only known case where oocyte donation involved twin sisters. As with all types of donor gamete therapy, pre-treatment counselling is important in the circumstance of sister oocyte donation.
Highlights
Premature ovarian failure (POF) remains a clinically challenging entity because in vitro fertilisation (IVF) with donor oocytes is currently the only treatment known to be effective
Among women presenting for fertility treatment, those with premature ovarian failure (POF) comprise an important subset as about 1% of all women will have this diagnosis [1]
The couple had been attempting to achieve a pregnancy for 2 1/2 years. They had undergone two unsuccessful IVF cycles and a diagnosis of premature ovarian failure had been made after the second attempt
Summary
Premature ovarian failure (POF) remains a clinically challenging entity because in vitro fertilisation (IVF) with donor oocytes is currently the only treatment known to be effective. Among women presenting for fertility treatment, those with premature ovarian failure (POF) comprise an important subset as about 1% of all women will have this diagnosis [1]. Because POF is characterised by early loss of normal ovarian function before age 40, the unrecoverable loss of oocytes results in a bleak fertility prognosis unless oocyte donation with IVF is used. Contemporary research has identified some genetic causes of POF, implicating a close association with Fragile × syndrome [2] and mutations in the inhibin alpha subunit gene [3]. Fragile × mental retardation-1 (FMR1) contains an unstable sequence of CGG trinucleotide repeats
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.